Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

Patient Navigation: Addressing Social Challenges in Dialysis Patients.

Cervantes L, Hasnain-Wynia R, Steiner JF, Chonchol M, Fischer S.

Am J Kidney Dis. 2019 Sep 9. pii: S0272-6386(19)30860-1. doi: 10.1053/j.ajkd.2019.06.007. [Epub ahead of print]

PMID:
31515136
2.

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

Beddhu S, Shen J, Cheung AK, Kimmel PL, Chertow GM, Wei G, Boucher RE, Chonchol M, Arman F, Campbell RC, Contreras G, Dwyer JP, Freedman BI, Ix JH, Kirchner K, Papademetriou V, Pisoni R, Rocco MV, Whelton PK, Greene T.

J Am Soc Nephrol. 2019 Aug;30(8):1523-1533. doi: 10.1681/ASN.2018121261. Epub 2019 Jul 19.

PMID:
31324734
3.

Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.

Garimella PS, Lee AK, Ambrosius WT, Bhatt U, Cheung AK, Chonchol M, Craven T, Hawfield AT, Jotwani V, Killeen A, Punzi H, Sarnak MJ, Wall BM, Ix JH, Shlipak MG.

Eur Heart J. 2019 Jun 30. pii: ehz392. doi: 10.1093/eurheartj/ehz392. [Epub ahead of print]

PMID:
31257404
4.

Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT.

Derington CG, Gums TH, Bress AP, Herrick JS, Greene TH, Moran AE, Weintraub WS, Kronish IM, Morisky DE, Trinkley KE, Saseen JJ, Reynolds K, Bates JT, Berlowitz DR, Chang TI, Chonchol M, Cushman WC, Foy CG, Herring CT, Katz LA, Krousel-Wood M, Pajewski NM, Tamariz L, King JB; SPRINT Research Group.

Hypertension. 2019 Jul 1:HYPERTENSIONAHA11912907. doi: 10.1161/HYPERTENSIONAHA.119.12907. [Epub ahead of print]

PMID:
31256717
5.

Incident infection following acute kidney injury with recovery to baseline creatinine: A propensity score matched analysis.

Griffin BR, You Z, Holmen J, SooHoo M, Gist KM, Colbert JF, Chonchol M, Faubel S, Jovanovich A.

PLoS One. 2019 Jun 24;14(6):e0217935. doi: 10.1371/journal.pone.0217935. eCollection 2019.

6.

IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD.

Hung AM, Tsuchida Y, Nowak KL, Sarkar S, Chonchol M, Whitfield V, Salas N, Dikalova A, Yancey PG, Huang J, Linton MF, Ikizler TA, Kon V.

Clin J Am Soc Nephrol. 2019 May 7;14(5):702-711. doi: 10.2215/CJN.04360418. Epub 2019 Apr 23.

PMID:
31015261
7.

Serum Sodium and Pulse Pressure in SPRINT.

Nowak KL, Chonchol M, Jovanovich A, You Z, Bates J, Foy C, Glasser S, Killeen AA, Kostis J, Rodriguez CJ, Segal M, Simmons DL, Taylor A, Lovato LC, Ambrosius WT, Supiano MA; SPRINT Research Group.

Am J Hypertens. 2019 Jun 11;32(7):649-656. doi: 10.1093/ajh/hpz055.

PMID:
30977767
8.

Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.

Jovanovich A, You Z, Isakova T, Nowak K, Cheung A, Wolf M, Chonchol M, Kendrick J.

Am J Nephrol. 2019;49(4):263-270. doi: 10.1159/000497445. Epub 2019 Feb 28.

PMID:
30820005
9.

Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.

Nowak KL, Gitomer B, Farmer-Bailey H, Wang W, Malaczewski M, Klawitter J, You Z, George D, Patel N, Jovanovich A, Chonchol M.

Am J Kidney Dis. 2019 Aug;74(2):213-223. doi: 10.1053/j.ajkd.2018.12.037. Epub 2019 Feb 23.

PMID:
30803706
10.

Peer Navigator Intervention for Latinos on Hemodialysis: A Single-Arm Clinical Trial.

Cervantes L, Chonchol M, Hasnain-Wynia R, Steiner JF, Havranek E, Hull M, Rice J, Kendrick J, Alamillo X, Camacho C, Fischer S.

J Palliat Med. 2019 Jul;22(7):838-843. doi: 10.1089/jpm.2018.0439. Epub 2019 Jan 31.

PMID:
30702365
11.

Risk of adverse maternal and fetal outcomes during pregnancy in living kidney donors: A matched cohort study.

Davis S, Dylewski J, Shah PB, Holmen J, You Z, Chonchol M, Kendrick J.

Clin Transplant. 2019 Jan;33(1):e13453. doi: 10.1111/ctr.13453. Epub 2018 Dec 9.

PMID:
30472740
12.

Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD.

Prasad PV, Li W, Raj DS, Carr J, Carr M, Thacker J, Li LP, Wang C, Sprague SM, Ix JH, Chonchol M, Block G, Cheung AK, Raphael K, Gassman J, Wolf M, Fried LF, Isakova T; CKD Optimal Management with BInders and NicotinamidE (COMBINE) study group.

Kidney Int Rep. 2018 Jul 7;3(6):1467-1472. doi: 10.1016/j.ekir.2018.07.006. eCollection 2018 Nov. No abstract available.

13.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
14.

Effects of L-Carnitine on Mineral Metabolism in the Multicentre, Randomized, Double Blind, Placebo-Controlled CARNIDIAL Trial.

Mercadal L, Tezenas du Montcel S, Chonchol MB, Debure A, Depreneuf H, Servais A, Bassilios N, Assogba U, Allouache M, Prié D.

Am J Nephrol. 2018;48(5):349-356. doi: 10.1159/000494338. Epub 2018 Nov 8.

PMID:
30408788
15.

Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.

Zhang WR, Craven TE, Malhotra R, Cheung AK, Chonchol M, Drawz P, Sarnak MJ, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23.

PMID:
30357395
16.

Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.

Andrews ES, Perrenoud L, Nowak KL, You Z, Pasch A, Chonchol M, Kendrick J, Jalal D.

PLoS One. 2018 Oct 24;13(10):e0205831. doi: 10.1371/journal.pone.0205831. eCollection 2018.

17.

The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

Melamed ML, Chonchol M, Gutiérrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R.

Am J Kidney Dis. 2018 Dec;72(6):834-845. doi: 10.1053/j.ajkd.2018.06.031. Epub 2018 Oct 5. Review.

PMID:
30297082
18.

Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.

Malhotra R, Craven T, Ambrosius WT, Killeen AA, Haley WE, Cheung AK, Chonchol M, Sarnak M, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Am J Kidney Dis. 2019 Jan;73(1):21-30. doi: 10.1053/j.ajkd.2018.07.015. Epub 2018 Oct 2.

PMID:
30291012
19.

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants.

Supiano MA, Lovato L, Ambrosius WT, Bates J, Beddhu S, Drawz P, Dwyer JP, Hamburg NM, Kitzman D, Lash J, Lustigova E, Miracle CM, Oparil S, Raj DS, Weiner DE, Taylor A, Vita JA, Yunis R, Chertow GM, Chonchol M.

PLoS One. 2018 Sep 26;13(9):e0203305. doi: 10.1371/journal.pone.0203305. eCollection 2018.

20.

CD8+ T cells modulate autosomal dominant polycystic kidney disease progression.

Kleczko EK, Marsh KH, Tyler LC, Furgeson SB, Bullock BL, Altmann CJ, Miyazaki M, Gitomer BY, Harris PC, Weiser-Evans MCM, Chonchol MB, Clambey ET, Nemenoff RA, Hopp K.

Kidney Int. 2018 Dec;94(6):1127-1140. doi: 10.1016/j.kint.2018.06.025. Epub 2018 Sep 21.

21.

Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study.

Kendrick J, Shah P, Andrews E, You Z, Nowak K, Pasch A, Chonchol M.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1463-1470. doi: 10.2215/CJN.00380118. Epub 2018 Sep 20.

22.

Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease.

Nowak KL, Wang W, Farmer-Bailey H, Gitomer B, Malaczewski M, Klawitter J, Jovanovich A, Chonchol M.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1493-1501. doi: 10.2215/CJN.05850518. Epub 2018 Sep 18.

23.

Young Kidney Professionals' Perspectives and Attitudes about Consuming Scientific Information: A Focus Group Study.

Tong A, Crews DC, Schell JO, de Boer IH, Chonchol M, Mehrotra R.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1587-1597. doi: 10.2215/CJN.01760218. Epub 2018 Aug 24.

24.

Circumstances of Death among Undocumented Immigrants Who Rely on Emergency-Only Hemodialysis.

Cervantes L, O'Hare A, Chonchol M, Hull M, Van Bockern J, Thompson M, Zoucha J.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1405-1406. doi: 10.2215/CJN.03440318. Epub 2018 Jul 13. No abstract available.

25.

Curcumin supplementation and motor-cognitive function in healthy middle-aged and older adults.

Santos-Parker JR, Lubieniecki KL, Rossman MJ, Van Ark HJ, Bassett CJ, Strahler TR, Chonchol MB, Justice JN, Seals DR.

Nutr Healthy Aging. 2018 Jun 15;4(4):323-333. doi: 10.3233/NHA-170029.

26.

Symptom Burden among Latino Patients with End-Stage Renal Disease and Access to Standard or Emergency-Only Hemodialysis.

Cervantes L, Hull M, Keniston A, Chonchol M, Hasnain-Wynia R, Fischer S.

J Palliat Med. 2018 Sep;21(9):1329-1333. doi: 10.1089/jpm.2017.0663. Epub 2018 May 30.

PMID:
29847204
27.

Clinicians' Perspectives on Providing Emergency-Only Hemodialysis to Undocumented Immigrants: A Qualitative Study.

Cervantes L, Richardson S, Raghavan R, Hou N, Hasnain-Wynia R, Wynia MK, Kleiner C, Chonchol M, Tong A.

Ann Intern Med. 2018 Jul 17;169(2):78-86. doi: 10.7326/M18-0400. Epub 2018 May 22.

PMID:
29800062
28.

Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.

Beddhu S, Greene T, Boucher R, Cushman WC, Wei G, Stoddard G, Ix JH, Chonchol M, Kramer H, Cheung AK, Kimmel PL, Whelton PK, Chertow GM.

Lancet Diabetes Endocrinol. 2018 Jul;6(7):555-563. doi: 10.1016/S2213-8587(18)30099-8. Epub 2018 Apr 21.

29.

Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults.

Rossman MJ, Santos-Parker JR, Steward CAC, Bispham NZ, Cuevas LM, Rosenberg HL, Woodward KA, Chonchol M, Gioscia-Ryan RA, Murphy MP, Seals DR.

Hypertension. 2018 Jun;71(6):1056-1063. doi: 10.1161/HYPERTENSIONAHA.117.10787. Epub 2018 Apr 16.

30.

Nail in the Coffin for Fibroblast Growth Factor 23 as a Predictor of Kidney Function Decline.

Jovanovich AJ, Chonchol MB.

Am J Nephrol. 2018;47(4):239-241. doi: 10.1159/000488363. Epub 2018 Apr 3. No abstract available.

31.

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.

Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR.

Nat Commun. 2018 Mar 29;9(1):1286. doi: 10.1038/s41467-018-03421-7.

32.

Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.

Schroeder EB, Chonchol M, Shetterly SM, Powers JD, Adams JL, Schmittdiel JA, Nichols GA, O'Connor PJ, Steiner JF.

Clin J Am Soc Nephrol. 2018 May 7;13(5):727-734. doi: 10.2215/CJN.09510817. Epub 2018 Mar 23.

33.

Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults.

Dobre M, Gaussoin SA, Bates JT, Chonchol MB, Cohen DL, Hostetter TH, Raphael KL, Taylor AA, Lerner AJ, Wright JT Jr, Rahman M; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):596-603. doi: 10.2215/CJN.07050717. Epub 2018 Mar 22.

34.

Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder: A Randomized Clinical Trial.

Zelnick LR, de Boer IH, Kestenbaum BR, Chonchol M, Kendrick J.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):927-928. doi: 10.2215/CJN.00480118. Epub 2018 Mar 7. No abstract available.

35.

Does inflammation affect outcomes in dialysis patients?

Nowak KL, Chonchol M.

Semin Dial. 2018 Jul;31(4):388-397. doi: 10.1111/sdi.12686. Epub 2018 Mar 7. Review.

36.

Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, Merriman TR, Moe OW, Mount DB, Sanchez Lozada LG, Stahl E, Weiner DE, Chertow GM.

Am J Kidney Dis. 2018 Jun;71(6):851-865. doi: 10.1053/j.ajkd.2017.12.009. Epub 2018 Feb 27. Review.

PMID:
29496260
37.

Serum Sodium and Cognition in Older Community-Dwelling Men.

Nowak KL, Yaffe K, Orwoll ES, Ix JH, You Z, Barrett-Connor E, Hoffman AR, Chonchol M.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):366-374. doi: 10.2215/CJN.07400717. Epub 2018 Feb 8.

38.

Dietary Sodium/Potassium Intake Does Not Affect Cognitive Function or Brain Imaging Indices.

Nowak KL, Fried L, Jovanovich A, Ix J, Yaffe K, You Z, Chonchol M.

Am J Nephrol. 2018;47(1):57-65. doi: 10.1159/000486580. Epub 2018 Jan 24.

39.

Strategies for Achieving Healthy Vascular Aging.

Nowak KL, Rossman MJ, Chonchol M, Seals DR.

Hypertension. 2018 Mar;71(3):389-402. doi: 10.1161/HYPERTENSIONAHA.117.10439. Epub 2018 Jan 8. Review. No abstract available.

40.

Associations of Dietary Protein and Energy Intakes With Protein-Energy Wasting Syndrome in Hemodialysis Patients.

Beddhu S, Wei G, Chen X, Boucher R, Kiani R, Raj D, Chonchol M, Greene T, Murtaugh MA.

Kidney Int Rep. 2017 Apr 18;2(5):821-830. doi: 10.1016/j.ekir.2017.04.002. eCollection 2017 Sep.

41.

CJASN: What's Behind and What's Ahead.

Mehrotra R, Chonchol M, de Boer I.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):3. doi: 10.2215/CJN.13321117. Epub 2017 Dec 21. No abstract available.

42.

The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study.

Ginsberg C, Katz R, de Boer IH, Kestenbaum BR, Chonchol M, Shlipak MG, Sarnak MJ, Hoofnagle AN, Rifkin DE, Garimella PS, Ix JH.

Bone. 2018 Feb;107:124-130. doi: 10.1016/j.bone.2017.11.011. Epub 2017 Nov 16.

43.

Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.

Nowak KL, You Z, Gitomer B, Brosnahan G, Torres VE, Chapman AB, Perrone RD, Steinman TI, Abebe KZ, Rahbari-Oskoui FF, Yu ASL, Harris PC, Bae KT, Hogan M, Miskulin D, Chonchol M.

J Am Soc Nephrol. 2018 Feb;29(2):571-578. doi: 10.1681/ASN.2017070819. Epub 2017 Nov 8.

44.

Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
.

Nowak KL, Chonchol M, You Z, Gupta M, Gitomer B.

Clin Nephrol. 2018 Mar;89(3):196-204. doi: 10.5414/CN109247.

45.

Associations of Protein-Energy Wasting Syndrome Criteria With Body Composition and Mortality in the General and Moderate Chronic Kidney Disease Populations in the United States.

Beddhu S, Chen X, Wei G, Raj D, Raphael KL, Boucher R, Chonchol MB, Murtaugh MA, Greene T.

Kidney Int Rep. 2017 May;2(3):390-399. doi: 10.1016/j.ekir.2017.01.002. Epub 2017 Jan 10.

46.

Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Jovanovich A, Isakova T, Block G, Stubbs J, Smits G, Chonchol M, Miyazaki M.

Am J Kidney Dis. 2018 Jan;71(1):27-34. doi: 10.1053/j.ajkd.2017.06.017. Epub 2017 Aug 9.

47.

Perspective on Nephrology Fellowship in the United States.

Chonchol M.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1714. doi: 10.2215/CJN.07060717. Epub 2017 Aug 8. No abstract available.

48.

Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.

Kendrick J, Andrews E, You Z, Moreau K, Nowak KL, Farmer-Bailey H, Seals DR, Chonchol M.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1438-1446. doi: 10.2215/CJN.01870217. Epub 2017 Aug 7.

49.

APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial.

Freedman BI, Rocco MV, Bates JT, Chonchol M, Hawfield AT, Lash JP, Papademetriou V, Sedor JR, Servilla K, Kimmel PL, Wall BM, Pajewski NM; SPRINT Research Group.

Kidney Int Rep. 2017 Jul;2(4):713-720. doi: 10.1016/j.ekir.2017.03.008. Epub 2017 Mar 31.

50.

A guiding map for inflammation.

Netea MG, Balkwill F, Chonchol M, Cominelli F, Donath MY, Giamarellos-Bourboulis EJ, Golenbock D, Gresnigt MS, Heneka MT, Hoffman HM, Hotchkiss R, Joosten LAB, Kastner DL, Korte M, Latz E, Libby P, Mandrup-Poulsen T, Mantovani A, Mills KHG, Nowak KL, O'Neill LA, Pickkers P, van der Poll T, Ridker PM, Schalkwijk J, Schwartz DA, Siegmund B, Steer CJ, Tilg H, van der Meer JWM, van de Veerdonk FL, Dinarello CA.

Nat Immunol. 2017 Jul 19;18(8):826-831. doi: 10.1038/ni.3790.

Supplemental Content

Loading ...
Support Center